Literature DB >> 28941731

Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.

Bianca Zingales1.   

Abstract

The genetic diversity of Trypanosoma cruzi, the protozoan agent of Chagas disease, is widely recognized. At present, T. cruzi is partitioned into seven discrete typing units (DTUs), TcI-TcVI and Tcbat. This article reviews the present knowledge on the parasite population structure, the evolutionary relationships among DTUs and their distinct, but not exclusive ecological and epidemiological associations. Different models for the origin of hybrid DTUs are examined, which agree that genetic exchange among T. cruzi populations is frequent and has contributed to the present parasite population structure. The geographic distribution of the prevalent DTUs in humans from the southern United States to Argentina is here presented and the circumstantial evidence of a possible association between T. cruzi genotype and Chagas disease manifestations is discussed. The available information suggests that parasite strains detected in patients, regardless of the clinical presentation, reflect the principal DTU circulating in the domestic transmission cycles of a particular region. In contrast, in several orally transmitted outbreaks, sylvatic strains are implicated. As a consequence of the genotypic and phenotypic differences of T. cruzi strains and the differential geographic distribution of DTUs in humans, regional variations in the sensitivity of the serological tests are verified. The natural resistance to benznidazole and nifurtimox, verified in vivo and in vitro for some parasite stocks, is not associated with any particular DTU, and does not explain the marked difference in the anti-parasitic efficacy of both drugs in the acute and chronic phases of Chagas disease. Throughout this review, it is emphasized that the interplay between parasite and host genetics should have an important role in the definition of Chagas disease pathogenesis, anti-T. cruzi immune response and chemotherapy outcome and should be considered in future investigations.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chagas disease pathology; Chemotherapy; Hybridization; Serological diagnosis; Trypanosoma cruzi discrete typing units; immune response

Mesh:

Substances:

Year:  2017        PMID: 28941731     DOI: 10.1016/j.actatropica.2017.09.017

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  92 in total

1.  Tetrahydrophthalazinone Inhibitor of Phosphodiesterase with In Vitro Activity against Intracellular Trypanosomatids.

Authors:  Julianna Siciliano de Araújo; Raiza Brandão Peres; Patrícia Bernardino da Silva; Marcos Meuser Batista; Geert Jan Sterk; Louis Maes; Guy Caljon; Rob Leurs; Harry P de Koning; Titilola D Kalejaiye; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  The Immunoglobulin M-Shed Acute Phase Antigen (SAPA)-test for the Early Diagnosis of Congenital Chagas Disease in the Time of the Elimination Goal of Mother-to-Child Transmission.

Authors:  Yagahira E Castro-Sesquen; Freddy Tinajeros; Caryn Bern; Gerson Galdos-Cardenas; Edith S Malaga; Edward Valencia Ayala; Kathryn Hjerrild; Steven J Clipman; Andrés G Lescano; Tabitha Bayangos; Walter Castillo; María Carmen Menduiña; Kawsar R Talaat; Robert H Gilman
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

3.  Phylogenetic Analysis of Trypanosoma cruzi from Pregnant Women and Newborns from Argentina, Honduras, and Mexico Suggests an Association of Parasite Haplotypes with Congenital Transmission of the Parasite.

Authors:  Claudia Herrera; Carine Truyens; Eric Dumonteil; Jackeline Alger; Sergio Sosa-Estani; Maria L Cafferata; Luz Gibbons; Alvaro Ciganda; Maria L Matute; Concepcion Zuniga; Yves Carlier; Pierre Buekens
Journal:  J Mol Diagn       Date:  2019-08-23       Impact factor: 5.568

Review 4.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

5.  Trypanosoma cruzi diversity in naturally infected nonhuman primates in Louisiana assessed by deep sequencing of the mini-exon gene.

Authors:  Claudia Herrera; Alicia Majeau; Peter Didier; Kathrine P Falkenstein; Eric Dumonteil
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-05-01       Impact factor: 2.184

6.  Use of a Latent Class Analysis in the Diagnosis of Chronic Chagas Disease in the Washington Metropolitan Area.

Authors:  Yagahira E Castro-Sesquen; Antonella Saldaña; Dhayanna Patino Nava; Tabitha Bayangos; Diana Paulette Evans; Kelly DeToy; Alexia Trevino; Rachel Marcus; Caryn Bern; Robert H Gilman; Kawsar R Talaat
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

7.  A Combination of Itraconazole and Amiodarone Is Highly Effective against Trypanosoma cruzi Infection of Human Stem Cell-Derived Cardiomyocytes.

Authors:  Gabriele Sass; Roy T Madigan; Lydia-Marie Joubert; Adriana Bozzi; Nazish Sayed; Joseph C Wu; David A Stevens
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

8.  Mice Intragastric Infected with Insect and Blood Trypomastigotes of Trypanosoma cruzi IV: Differences and Similarities on the Evolution Profile and Response to Etiological Treatment.

Authors:  Miyoko Massago; Gerson Zanusso Junior; Elaine Schultz Dworak; Elisama Loubak da Silva; Alexandre Tadachi Morey; Mônica Lúcia Gomes; Max Jean de Ornelas Toledo
Journal:  Acta Parasitol       Date:  2021-04-23       Impact factor: 1.440

Review 9.  Serological Approaches for Trypanosoma cruzi Strain Typing.

Authors:  Virginia Balouz; Leonel Bracco; Alejandro D Ricci; Guadalupe Romer; Fernán Agüero; Carlos A Buscaglia
Journal:  Trends Parasitol       Date:  2021-01-09

Review 10.  Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death.

Authors:  Antonia Pino-Marín; Germán José Medina-Rincón; Sebastian Gallo-Bernal; Alejandro Duran-Crane; Álvaro Ignacio Arango Duque; María Juliana Rodríguez; Ramón Medina-Mur; Frida T Manrique; Julian F Forero; Hector M Medina
Journal:  Pathogens       Date:  2021-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.